No photo of Peter M Gordon
Contact Expert

View Scopus Profile

Peter M Gordon

 https://orcid.org/0000-0002-3159-1881
19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

An Open-Label, Multicenter Study of RC-P in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Following Hypersensitivity to E. coli-derived Asparaginases

Gordon, P. M.

Children's Hospital of Philadelphia

6/11/20 → 5/31/21

Project: Research project

    • Overcoming Leukemia Chemoresistance in the Central Nervous System

    Gordon, P. M.

    NIH NATIONAL CANCER INSTITUTE (NCI)

    3/4/20 → 2/28/25

    Project: Research project

    • One Time EOY, Integrated BIQSFP AAML1031- Echocardiogram Reports and Images

    Gordon, P. M.

    Children's Hospital of Philadelphia

    3/1/20 → 2/28/21

    Project: Research project

    A Phase 2 Study of Inotuzumab Ozogamicin in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)

    Gordon, P. M.

    Children's Hospital of Philadelphia

    2/27/19 → 2/28/21

    Project: Research project

    • Targeted Therapy of the Rare, Chemo-resistant Leukemia Cells that Contribute to Relapse

    Gordon, P. M.

    Hope on Wheels Hyundai Dealers

    10/22/18 → 12/30/20

    Project: Research project

    • Research Output

    Body mass index associated with childhood and adolescent high-risk B-cell acute lymphoblastic leukemia risk: A Children’s Oncology Group report

    Ghosh, T., Richardson, M., Gordon, P. M., Ryder, J. R., Spector, L. G. & Turcotte, L. M., 2020, (Accepted/In press) In : Cancer medicine.

    Research output: Contribution to journal › Article

    Open Access

    • The meninges enhance leukaemia survival in cerebral spinal fluid

    Basile, P., Jonart, L. M., Ebadi, M., Johnson, K., Kerfeld, M. & Gordon, P. M., Jan 1 2020, (Accepted/In press) In : British journal of haematology.

    Research output: Contribution to journal › Article

    • Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia

    Ebadi, M., Wasko, J., Weisdorf, D. J., Gordon, P. M. & Rashidi, A., Oct 1 2019, In : British journal of haematology. 187, 1, p. e24-e27

    Research output: Contribution to journal › Article

    Open Access
    2 Scopus citations

    SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit in Vitro and in Vivo Efficacy

    Naumann, J. A., Widen, J. C., Jonart, L. A., Ebadi, M., Tang, J., Gordon, D. J., Harki, D. A. & Gordon, P. M., Apr 18 2018, In : Bioconjugate Chemistry. 29, 4, p. 1111-1118 8 p.

    Research output: Contribution to journal › Article

    • 5 Scopus citations

    In vitro model of leukemia cell migration across the blood–cerebrospinal fluid barrier

    Naumann, J. A. & Gordon, P. M., Jul 3 2017, In : Leukemia and Lymphoma. 58, 7, p. 1747-1749 3 p.

    Research output: Contribution to journal › Letter

    4 Scopus citations

    Press / Media

    U researchers aim to create new therapies for pediatric leukemia

    David J Odde & Peter M Gordon

    5/4/20

    2 items of Media coverage

    Press/Media: Expert Comment